Diazoxide 50mg/mL; chocolate-mint flavor; contains alcohol 7.25%. Diazoxide administered orally produces a prompt dose-related increase in blood glucose level, due primarily to an inhibition of ...

An NDA for its lead candidate, DCCR (diazoxide choline) extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS) is currently under review by the FDA and ...